Ready to Improve Your Biomarker Intelligence?

TALK TO A BIOMARKER STRATEGIST

Empower Your Team With The Right Pharma Intelligence at The Right Time

Amplion synthesizes the world’s entire biomedical evidence landscape with targeted machine learning to analyze and prioritize the insights that are most important to your product strategy and business development.
Timely Intelligence Has Never Been More Valuable –
or Challenging to Acquire

85,000

Active clinical trials that define your product landscape

100/day

New trials published – each one a potential high-value opportunity

3-6 Months

Time required to analyze opportunity landscape without Amplion
Fully-qualified Product Opportunities
Tailored to Your Strategic Goals
Efficient Access to Relevant Evidence

All the world’s biomedical evidence and drug development activity precisely tailored to match your product capabilities and ideal customer profile, giving you relevant, unbiased insights in an instant.
Drive Growth with Actionable Insights

Targeted visibility into pharma and test developer activities tailored to your needs and continuous monitoring enables you to discover new product and technology insights and identify new partnership opportunities at exactly the right time so you can take action.
Confident Decision Making

Comprehensive analysis, data-driven insights and ongoing monitoring of the precision medicine landscape arms your product strategy and business development teams with confidence for decision-making in a competitive environment.
The Challenge

Drug and test developers face numerous challenges in today’s age of targeted therapies. Building the right tests and identifying partnership opportunities to drive precision medicine forward is just one of them.

In today’s era of shifting commercial landscapes, industry leaders recognize that to fully realize the promise of personalized medicine, a new model of collaboration between drug and test developers is essential for success. For many test developers, identifying and building relationships with the right Pharma partners early in their drug development process can be timely and expensive. Too often, it requires manually sifting through public databases, publications, conference materials, media and social channels in search of prospects, leaving the most high-value opportunities discovered too late or not at all.
What if?

What if there were an advanced intelligence platform that leverages machine learning that could help you automatically discover the evidence that is relevant to your current product capabilities and your emerging opportunities, and then continuously scan the entire biomedical evidence landscape for compelling events that deliver the highest priority opportunities based on your unique testing capabilities – enabling you to engage with the right players at the right time to drive revenue growth?
The Solution

Precisely tailored insights delivered in real time so you can focus on what matters most. 

Amplion’s Dx: Product Strategy and Dx: Revenue solutions deliver tailored results based on your technology expertise and development program goals.

Unlike traditional informatics services, Amplion’s proprietary platform leverages deep learning to deliver the most relevant opportunity matches based on your ideal customer profile and product capabilities, giving you powerful insights based on your role.

Our platform continuously scans the entire biomedical evidence landscape in real time to equip you with the actionable insights you need to drive growth.
What Makes Amplion Different
Customized, prioritized product planning and partnering opportunities paired with comprehensive, real-time evidence monitoring delivers the difference
Powerful, Contextual Machine Learning
No need to review every clinical trial or press release. Amplion’s ML is powered by expert annotations and a comprehensive synonym ontology to ensure that evidence is contextually relevant to your product strategy.
Immediate Access to Relevant Evidence
Real-time processing of the entire biomedical landscape, including clinical trials, research pubs, conference abstracts, press releases, company financials, FDA filings, drug labels and more.
Fully-qualified Product Opportunities
Discover high-value and precisely qualified product opportunities that are perfectly aligned to your strategic priorities, including product capabilities, clinical development activity and partner financial health.
“With Amplion, we identified a white space market opportunity enabling us to put together a solid business case that was presented to senior leadership and approved for funding. The product has become central to our growth strategy."

Chief Marketing Officer, Large Global Diagnostics Developer
Case Study:
How a leading Dx developer identified 80 full-qualified Pharma and Biotech partnering opportunities